Research progress in lipid metabolic regulation of bioactive peptides-Reference-Cited by-同舟云学术

Research progress in lipid metabolic regulation of bioactive peptides

Published:2023-02-06 Issue:1 Volume:5 Page:
ISSN:2661-8974
Container-title:Food Production, Processing and Nutrition
language:en
Short-container-title:Food Prod Process and Nutr

Author:

Ma Wenshu,Li Na,Lin Luan,Wen Jiahui,Zhao Chao^ORCID,Wang Fang

Abstract

AbstractHyperlipidemia poses a serious threat to human health and evaluating the ability of natural active substances to regulate disorders of lipid metabolism is the focus of food functionality research in recent years. Bioactive peptides are distinguished by their broad range of sources, high nutritional content, ease of absorption and use by the body, and ease of determining their sequences. Bioactive peptides have a wide range of potential applications in the area of medicines and food. The regulation of lipid metabolism disorder caused by bioactive peptides from different sources provides a reference for the development and research of bioactive peptides for lipid reduction. Graphical Abstract

Funder

Fujian Provincial Natural Science Foundation of China

Quanzhou Municipal Science and Technology Planning Project

Fujian Province Key Laboratory for the Development of Bioactive Material from Marine Algae

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Food Science

Link

https://link.springer.com/content/pdf/10.1186/s43014-022-00123-y.pdf

Reference68 articles.

1. Ahmadi, Y., Haghjoo, A. G., Dastmalchi, S., Nemati, M., & Bargahi, N. (2018). Effects of Rosuvastatin on the expression of the genes involved in cholesterol metabolism in rats: adaptive responses by extrahepatic tissues. Gene,661, 45–50. https://doi.org/10.1016/j.gene.2018.03.092

2. Ajeigbe, O. F., Oboh, G., Ademosun, A. O., & Oyagbemi, A. A. (2022). Ficus asperifolia miq-enriched biscuit diet protects against l-NAME induced hyperlipidemia and hypertension in rats. Food Frontiers, 3, 150–160. https://doi.org/10.1002/fft2.101.

3. Banno, A., Wang, J., Okada, K., Mori, R., Mijiti, M., & Nagaoka, S. (2019). Identification of a novel cholesterol-lowering dipeptide, phenylalanine-proline (FP), and its down-regulation of intestinal ABCA1 in hypercholesterolemic rats and Caco-2 cells. Scientific Reports, 9(1), 19416. https://doi.org/10.1038/s41598-019-56031-8.

4. Cagen, L. M., Deng, X., Wilcox, H. G., Park, E. A., Raghow, R., & Elam, M. B. (2005). Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. The Biochemical Journal, 385(Pt 1), 207–216. https://doi.org/10.1042/BJ20040162.

5. Cameron, K. O., & Kurumbail, R. G. (2016). Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators. Bioorganic & Medicinal Chemistry Letters, 26(21), 5139–5148. https://doi.org/10.1016/j.bmcl.2016.09.065.